Federal regulators will no longer require patients to provide blood tests before receiving the drug from pharmacies.

The symptoms of schizophrenia vary greatly from person to person. A new study appearing in the American Journal of Psychiatry ...

Study finds the biological heterogeneity of schizophrenia is reflected in structural irregularities of the brain as well as functional abnormalities.

The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescri ...

In fall 2024, xanomeline trospium chloride (XT) was approved by the U.S. Food and Drug Administration for the treatment of ...

Patients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to ...

The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the brain.

A new international study reveals that schizophrenia manifests differently in the brain, reflecting the wide range of symptoms among patients.

Feb. 26, 2025 — The symptoms of schizophrenia vary greatly from person to person. A new study shows how these differences manifest themselves in the structure of the ... Genetic Risk of ...

A new study has revealed that schizophrenia manifests differently in each person, with variations in brain structure ...

The first line of pharmacological treatment for schizophrenia is antipsychotic medication. However, antipsychotic medications are ineffective in more than 30% of people with the disorder. This is ...

Schizophrenia and bipolar disorder are severe mental disorders that often manifest in early adulthood. Effective treatments exist, but they require an accurate diagnosis—something that is more ...